Komori
Japan Animal Referral Medical Center (6039) · TargetSoftenedLatest Earnings presentation materials (2026-11-16): "Raised"

Next-period performance targets (net sales and profit)

First written in FY2018. 5 of 11 entries say "Raised", first in FY2023. Latest entry: 2026-11-16.

11entries
9years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAchievedFY2019OtherFY2021 – FY2022RaisedFY2023 – FY20242018: 120182019: 120192020: 020202021: 120212022: 120222023: 120232024: 120242025: 020252026: 52026
Same theme, other companies
Next Fiscal Year’s Net Sales and Profit PlanA theme 17 companies write about · 4 as a headwind · 13 as a tailwind

The whole theme swung hardest in 2019: 5 of 12 companies on the "Worse" side.

2 other companies' latest entry also says "Raised".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 17 companies compared. The sentences above are computed from all 17.
Full recordFilings, disclosures and news, newest first
  1. FY2026SoftenedAnnual report

    「The Group sets forecast figures for each level of profit, accompanied by revenue growth and improvement in each profit margin, as management targets.」

    The specific forecast amounts for next-period revenue and profit disclosed previously were not presented in this filing; instead, it stated general targets of revenue growth and improved profit margins.
  2. FY2024RaisedAnnual report

    「As a result of these initiatives, the Company expects next consolidated fiscal year revenue of ¥4,820 million, operating profit of ¥625 million, ordinary profit of ¥625 million, and profit attributable to owners of the parent of ¥440 million.」

    The forecast for the next consolidated fiscal year was updated from the previous figures of revenue of ¥4,140 million, operating profit of ¥555 million, ordinary profit of ¥565 million, and net profit of ¥385 million to revenue of ¥4,820 million, operating profit of ¥625 million, ordinary profit of ¥625 million, and net profit of ¥440 million.
  3. FY2023RaisedAnnual report

    「As a result of these initiatives, the Company expects next consolidated fiscal year revenue of ¥4,140 million, operating profit of ¥555 million, ordinary profit of ¥565 million, and profit attributable to owners of the parent of ¥385 million.」

    The forecast for the next consolidated fiscal year was raised from the previous figures of revenue of ¥3,860 million, operating profit of ¥535 million, ordinary profit of ¥540 million, and net profit of ¥365 million to ¥4,140 million, ¥555 million, ¥565 million, and ¥385 million, respectively.
  4. FY2022Update to the Next-Period Earnings ForecastAnnual report

    「As a result of these initiatives, the Company expects next consolidated fiscal year revenue of ¥3,860 million, operating profit of ¥535 million, ordinary profit of ¥540 million, and profit attributable to owners of the parent of ¥365 million.」

    The forecast for the next consolidated fiscal year was updated to revenue of ¥3,860 million, operating profit of ¥535 million, ordinary profit of ¥540 million, and profit attributable to owners of the parent of ¥365 million.
  5. FY2021Update to the Next-Period Earnings ForecastAnnual report

    「As a result of these initiatives, the Company expects next consolidated fiscal year revenue of ¥2,930 million, operating profit of ¥410 million, ordinary profit of ¥420 million, and profit attributable to owners of the parent of ¥290 million.」

    The Company presented new next-period forecasts of revenue of ¥2,930 million, operating profit of ¥410 million, ordinary profit of ¥420 million, and net profit of ¥290 million.
  6. FY2019AchievedAnnual report

    「As a result, for the fiscal year, consolidated net sales were ¥2,563.690 million, up 13.5% year on year; operating income was ¥397.227 million, up 41.9%; ordinary income was ¥404.966 million, up 53.7%; and net income attributable to owners of the parent was ¥294.931 million, up 41.7%, resulting in higher sales and profits.」

    Actual results for the fiscal year ended March 2019 exceeded each of the next-period targets disclosed in the previous fiscal year: revenue of ¥2,560 million, operating profit of ¥350 million, ordinary profit of ¥350 million, and profit attributable to owners of the parent of ¥285 million.
  7. FY2018First statedAnnual report

    「As a result of these initiatives, the Company expects next-period revenue of ¥2,560 million, operating profit of ¥350 million, ordinary profit of ¥350 million, and profit attributable to owners of the parent of ¥285 million.」

    For the next period, the Company disclosed for the first time targets of revenue of ¥2,560 million, operating profit of ¥350 million, ordinary profit of ¥350 million, and profit attributable to owners of the parent of ¥285 million.
Moved together

"Expansion and strengthening of the affiliated-hospital network" moved the same way as this thread, in the same document, in 6 of its 11 moves.

665443★123456
  1. ★This thread
  2. 1Expansion and strengthening of the affiliated-hospital network6×
  3. 2Developing and Securing Outstanding Talent6×
  4. 3Providing State-of-the-Art Veterinary Care and Achieving Qualitative Growth5×
  5. 4Expansion of secondary-care facilities in major cities nationwide4×
  6. 5Peripheral Services Related to Veterinary Medicine and Development of an Integrated Platform4×
  7. 6Group Synergies and Sharing of Management Resources3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Japan Animal Referral Medical Center yet. It last moved in the Earnings presentation materials of 2026-11-16: "Raised".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Next-period performance targets (net sales and profit) | Japan Animal Referral Medical Center Co.,Ltd. (6039) | Komori